Approved by the Food and Drug Administration in 2004, the Phase
III Oxford Medial Partial Knee is used to treat anteromedial osteoarthritis
(AMOA) in patients with an intact anterior cruciate ligament. This
unicompartmental knee arthroplasty (UKA) is relatively new in the
United States, and therefore long-term American results are lacking. This is a single surgeon, retrospective study based on prospectively
collected data, analysing a consecutive series of primary UKAs using
the Phase III mobile-bearing Oxford Knee and Phase III instrumentation. Between July 2004 and December 2006, the senior author (RHE)
carried out a medial UKA in 173 patients (213 knees) for anteromedial
osteoarthritis or avascular necrosis (AVN). A total of 95 patients were men and 78 were women. Their mean
age at surgery was 67 years (38 to 89) and mean body mass index
29.87 kg/m2 (17 to 62). The mean follow-up was ten years (4 to 11).Aims
Patients and Methods
The February 2015 Knee Roundup360 looks at: Intra-operative sensors for knee balance; Mobile bearing no advantage; Death and knee replacement: a falling phenomenon; The swings and roundabouts of unicompartmental arthroplasty; Regulation, implants and innovation; The weight of arthroplasty responsibility!; BMI in arthroplasty
Over the past 30 years there have been many improvements
in implant fixation, correction of deformity, improved polyethylene
wear, and survival after knee replacement. The work over the last
decade has focused on less invasive surgical techniques, multimodal
pain management protocols, more rapid functional recovery and reduced
length of stay, aiming to minimise the side effects of treatment
while maintaining function and implant durability. When combined
and standardised these pre-, intra- and post-operative factors have
now facilitated outpatient knee replacement procedures for unicompartmental
replacement, patella femoral arthroplasty and total knee replacement
(TKR). We have found liposomal bupivacaine, with potential for longer
therapeutic action, to be a helpful adjunct and describe our current
pain management program. The next step in our multimodal program
is to improve the duration of patient satisfaction and reduce cost
and length of stay after TKR. Cite this article:
The use of robots in orthopaedic surgery is an
emerging field that is gaining momentum. It has the potential for significant
improvements in surgical planning, accuracy of component implantation
and patient safety. Advocates of robot-assisted systems describe
better patient outcomes through improved pre-operative planning
and enhanced execution of surgery. However, costs, limited availability,
a lack of evidence regarding the efficiency and safety of such systems
and an absence of long-term high-impact studies have restricted
the widespread implementation of these systems. We have reviewed
the literature on the efficacy, safety and current understanding of
the use of robotics in orthopaedics. Cite this article:
The December 2015 Knee Roundup360 looks at: Albumin and complications in knee arthroplasty; Tantalum: a knee fixation for all seasons?; Dynamic knee alignment; Tibial component design in UKA; Managing the tidal wave of revision knee arthroplasty; Scoring pain in TKR; Does anyone have a ‘normal’ tibial slope?; XLPE in TKR? A five-year clinical study; Spacers and infected revision arthroplasties; Dialysis and arthroplasty
The October 2015 Knee Roundup360 looks at: Allergy and outcome in arthroplasty; Physiotherapy and drains not such a bad combination?; Another nail in the coffin for arthroscopists?; Graft precondition hocus pocus; Extended dose steroids in knee arthritis?; Indolent peri-prosthetic infection; Computer modelling and medial knee arthritis
The aim of this study was to present data on 11 459 patients
who underwent total hip (THA), total knee (TKA) or unicompartmental
knee arthroplasty (UKA) between November 2002 and April 2014 with
aspirin as the primary agent for pharmacological thromboprophylaxis. We analysed the incidence of deep vein thrombosis (DVT) and pulmonary
embolism (PE) then compared the 90-day all-cause mortality with
the corresponding data in the National Joint Registry for England
and Wales (NJR). Aims
Patients and Methods
National registers compare implants by their revision rates, but the validity of the method has never been assessed. The New Zealand Joint Registry publishes clinical outcomes (Oxford knee scores, OKS) alongside revision rates, allowing comparison of the two measurements. In the two types of knee replacement, unicompartmental (UKR) had a better knee score than total replacement (TKR), but the revision rate of the former was nearly three times higher than that of the latter. This was because the sensitivity of the revision rate to clinical failure was different for the two implants. For example, of knees with a very poor outcome (OKS <
20 points), only about 12% of TKRs were revised compared with about 63% of UKRs with similar scores. Revision therefore is not an objective measurement and should not be used to compare these two types of implant. Furthermore, revision is much less sensitive than the OKS to clinical failure in both types and therefore exaggerates the success of knee replacements, particularly of TKR.
This study reports on the first 150 consecutive
Oxford cementless unicompartmental knee arthroplasties (UKA) performed
in an independent centre (126 patients). All eligible patients had
functional scores (Oxford knee score and high activity arthroplasty
score) recorded pre-operatively and at two- and five-years of follow-up. Fluoroscopically
aligned radiographs were taken at five years and analysed for any
evidence of radiolucent lines (RLLs), subsidence or loosening. The
mean age of the cohort was 63.6 years (39 to 86) with 81 (53.1%)
males. Excellent functional scores were maintained at five years
and there were no progressive RLLs demonstrated on radiographs.
Two patients underwent revision to a total knee arthroplasty giving
a revision rate of 0.23/100 (95% confidence interval 0.03 to 0.84)
component years with overall component survivorship of 98.7% at
five years. There were a further four patients who underwent further
surgery on the same knee, two underwent bearing exchanges for dislocation
and two underwent lateral UKAs for disease progression. This was
a marked improvement from other UKAs reported in New Zealand Joint
Registry data and supports the designing centre’s early results. Cite this article:
This is the second of a series of reviews of registries. This review looks specifically at worldwide registry data that have been collected on knee arthroplasty, what we have learned from their reports, and what the limitations are as to what we currently know.
This prospective study reports the 15-year survival and ten-year
functional outcome of a consecutive series of 1000 minimally invasive
Phase 3 Oxford medial UKAs (818 patients, 393 men, 48%, 425 women,
52%, mean age 66 years; 32 to 88). These were implanted by two surgeons
involved with the design of the prosthesis to treat anteromedial
osteoarthritis and spontaneous osteonecrosis of the knee, which
are recommended indications. Patients were prospectively identified
and followed up independently for a mean of 10.3 years (5.3 to 16.6). At ten years, the mean Oxford Knee Score was 40 (standard deviation
( This is the only large series of minimally invasive UKAs with
15-year survival data. The results support the continued use of
minimally invasive UKA for the recommended indications. Cite this article:
The October 2013 Knee Roundup360 looks at: Make it easy, release the MCL; Do patients remember clinical information in day surgery?; Osteoarthritis and arthroscopy?; How best to double your bundles; When to operate for infection; Cementless unicompartment knee replacement?; Tibial tubercle-trochlear groove confusion; Tarts, cherries and osteoarthritis
This randomised trial evaluated the outcome of
a single design of unicompartmental arthroplasty of the knee (UKA) with
either a cemented all-polyethylene or a metal-backed modular tibial
component. A total of 63 knees in 45 patients (17 male, 28 female)
were included, 27 in the all-polyethylene group and 36 in the metal-backed
group. The mean age was 57.9 years (39.6 to 76.9). At a mean follow-up
of 6.4 years (5 to 9.9), 11 all-polyethylene components (41%) were
revised (at a mean of 5.8 years; 1.4 to 8.0) post-operatively and
two metal-backed components were revised (at one and five years).
One revision in both groups was for unexplained pain, one in the
metal-backed group was for progression of osteoarthritis. The others
in the all-polyethylene group were for aseptic loosening. The survivorship
at seven years calculated by the Kaplan–Meier method for the all-polyethylene
group was 56.5% (95% CI 31.9 to 75.2, number at risk 7) and for
the metal-backed group was 93.8% (95% CI 77.3 to 98.4, number at
risk 16) This difference was statistically significant (p <
0.001).
At the most recent follow-up, significantly better mean Western
Ontario and McMaster Universities Arthritis Index Scores were found
in the all-polyethylene group (13.4 This randomised study demonstrates that all-polyethylene components
in this design of fixed bearing UKA had unsatisfactory results with
significantly higher rates of failure before ten years compared
with the metal-back components. Cite this article:
We assessed the outcome of patients who were
lost to follow-up after arthroplasty by a single surgeon. The aim was
to validate the surgeon’s data set with the Australian Orthopaedic
Association National Joint Replacement Registry and determine the
outcome of those patients lost to follow-up. Prospective data on patient demographics, operative details and
outcomes of the surgeon’s 1192 primary unicompartmental knee arthroplasty
(UKA) procedures were analysed. There were 69 knees in patients
who were lost to follow-up, among whom the Registry identified 31
deaths and eight revisions. The cumulative percentage revision (CPR) at seven years using
the additional Registry data was 8.8% (95% confidence interval (CI)
7 to 11). Using the surgeon’s data, the CPR at seven years was 8%
(95% CI 6.3 to 10.1) for the best-case scenario where loss to follow-up
was excluded, and 16% (95% CI 13.8 to 19.4) for the worst-case scenario, where
all patients lost to follow-up were deemed to have been revised.
There was a significantly higher mortality rate in those patients
lost to follow-up. This study demonstrates that a national joint registry can be
used by individual surgeons to establish more accurate revision
rates in their arthroplasty patients. This is expected to facilitate
a more rigorous audit of surgical outcomes by surgeons and lead
to more accurate and uniform reporting of the results of arthroplasty
in general.
This prospective study describes the complications and survival of the first 688 Phase 3 Oxford medial unicompartmental knee replacements implanted using a minimally-invasive technique by two surgeons and followed up independently. None was lost to follow-up. We had carried out 132 of the procedures more than five years ago. The clinical assessment of 101 of these which were available for review at five years is also presented. Nine of the 688 knees were revised: four for infection, three for dislocation of the bearing and two for unexplained pain. A further seven knees (1%) required other procedures: four had a manipulation under anaesthesia, two an arthroscopy and one a debridement for superficial infection. The survival rate at seven years was 97.3% (95% confidence interval 5.3). At five years, 96% of the patients had a good or excellent American Knee Society score, the mean Oxford knee score was 39 and the mean flexion was 133°. This study demonstrates that the minimally-invasive Oxford unicompartmental knee replacement is a reliable and effective procedure.
We analysed whether a high body mass index (BMI)
had a deleterious effect on outcome following autologous chondrocyte
implantation (ACI) or matrix-carried autologous chondrocyte implantation
(MACI) for the treatment of full-thickness chondral defects of the
knee from a subset of patients enrolled in the ACI vs MACI trial
at The Royal National Orthopaedic Hospital. The mean Modified Cincinnati scores (MCS) were significantly
higher (p <
0.001) post-operatively in patients who had an ideal
body weight (n = 53; 20 to 24.9 kg/m2) than in overweight
(n = 63; 25 to 30 kg/m2) and obese patients (n = 22;
>
30 kg/m2). At a follow-up of two years, obese patients
demonstrated no sustained improvement in the MCS. Patients with
an ideal weight experienced significant improvements as early as
six months after surgery (p = 0.007). In total, 82% of patients
(31 of 38) in the ideal group had a good or excellent result, compared
with 49% (22 of 45) of the overweight and 5.5% (one of 18) in the
obese group (p <
0.001). There was a significant negative relationship between
BMI and the MCS 24 months after surgery (r = -0.4, p = 0.001). This study demonstrates that obese patients have worse knee function
before surgery and experience no sustained benefit from ACI or MACI
at two years after surgery. There was a correlation between increasing
BMI and a lower MCS according to a linear regression analysis. On
the basis of our findings patient selection can be more appropriately
targeted.
In a global environment of rising costs and limited funds, robotic and computer-assisted orthopaedic technologies could provide the means to drive a necessary revolution in arthroplasty productivity. Robots have been used to operate on humans for 20 years, but the adoption of the technology has lagged behind that of the manufacturing industry. The use of robots in surgery should enable cost savings by reducing instrumentation and inventories, and improving accuracy. Despite these benefits, the orthopaedic community has been resistant to change. If the ergonomics and economics are right, robotic technology just might transform the provision of joint replacement.
The October 2014 Knee Roundup360 looks at: microfracture equivalent to OATS; examination better than MRI in predicting hamstrings re-injury; a second view on return to play with hamstrings injuries; dislocation risks in the Oxford Unicompartmental Knee; what about the tibia?; getting on top of lateral facet pain post TKR; readmission in TKR; patient-specific instrumentation; treating infrapatellar saphenous neuralgia; and arthroscopy in the middle-aged.
Aseptic loosening of the femoral component is
an important indication for revision surgery in unicompartmental knee
replacement (UKR). A new design of femoral component with an additional
peg was introduced for the cemented Oxford UKR to increase its stability.
The purpose of this study was to compare the primary stability of
the two designs of component. Medial Oxford UKR was performed in 12 pairs of human cadaver
knees. In each pair, one knee received the single peg and one received
the twin peg design. Three dimensional micromotion and subsidence
of the component in relation to the bone was measured under cyclical
loading at flexion of 40° and 70° using an optical measuring system.
Wilcoxon matched pairs signed-rank test was performed to detect
differences between the two groups. There was no significant difference in the relative micromotion
(p = 0.791 and 0.380, respectively) and subsidence (p = 0.301 and
0.176, respectively) of the component between the two groups at
both angles of flexion. Both designs of component offered good strength
of fixation in this cadaver study. Cite this article:
The Unispacer knee system is a cobalt-chrome self-centring tibial hemiarthroplasty device for use in the treatment of isolated medial compartment osteoarthritis of the knee. The indications for use are similar to those for high tibial osteotomy, but insertion does not require bone cuts or component fixation, and does not compromise future knee replacement surgery. A prospective study of a consecutive series of 18 patients treated with the Unispacer between June 2003 and August 2004 was carried out to determine the early clinical results of this device. The mean age of the patients was 49 years (40 to 57). A total of eight patients (44%) required revision within two years. In two patients revision to a larger spacer was required, and in six conversion to either a unicompartmental or total knee replacement was needed. At the most recent review 12 patients (66.7%) had a Unispacer remaining This study demonstrates that use of the Unispacer in isolated medial compartment osteoarthritis is associated with a high rate of revision surgery and provides unpredictable relief of pain.